About EBOS Group
EBOS Group is a company based in Docklands (Australia) founded in 1922.. The company has 5,700 employees as of June 30, 2025. EBOS Group has completed 3 acquisitions, including LifeHealthcare, Symbion and TerryWhite Chemmart. EBOS Group offers products and services including Healthcare Distribution, Animal Care Products, and Medical Devices. EBOS Group operates in a competitive market with competitors including AmerisourceBergen, Arrow Pharmacueticals, Orspec Pharma, Alita Sales and HL Pharma, among others.
- Headquarter Docklands, Australia
- Employees 5700 as on 30 Jun, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ebos Group Ltd
-
Annual Revenue
$7.85 B (USD)-5.67as on Jun 30, 2025
-
Net Profit
$137.68 M (USD)-19.65as on Jun 30, 2025
-
EBITDA
$365.29 M (USD)-5.43as on Jun 30, 2025
-
Latest Funding Round
$123.75 M (USD), Post-IPO
Apr 11, 2025
-
Investors
-
Employee Count
5700
as on Jun 30, 2025
-
Investments & Acquisitions
LifeHealthcare
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of EBOS Group
EBOS Group is a publicly listed company on the NZX with ticker symbol EBO in New Zealand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of EBOS Group
EBOS Group offers a comprehensive portfolio of products and services, including Healthcare Distribution, Animal Care Products, and Medical Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Distributes healthcare and pharmaceutical products to businesses
Markets and distributes premium pet food and brands
Specializes in distribution of medical devices and solutions
Unlock access to complete
Unlock access to complete
Software Development Team
31 people
Finance and Accounting
14 people
Leadership Team
11 people
Human Resources and Administration
9 people
Senior Team
6 people
Product Management Team
6 people
Data Analysis and Operations Team
5 people
SAP Team
4 people
Unlock access to complete
Funding Insights of EBOS Group
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $123.7M
-
First Round
First Round
(30 Apr 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Post-IPO - EBOS Group | Valuation |
investors |
|
| Dec, 2021 | Amount | Post-IPO - EBOS Group | Valuation |
investors |
|
| Apr, 2019 | Amount | Post-IPO - EBOS Group | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by EBOS Group
EBOS Group has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include LifeHealthcare, Symbion and TerryWhite Chemmart. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medical devices and technologies are distributed across therapeutic areas.
|
2006 | ||||
|
Chain of pharmacy stores
|
1959 | ||||
|
Digital content, platforms, and infrastructure services are provided.
|
1845 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - EBOS Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ebos Group Comparisons
Competitors of EBOS Group
EBOS Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Arrow Pharmacueticals, Orspec Pharma, Alita Sales and HL Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provider of supply chain services for international trade
|
|
| domain | founded_year | HQ Location |
Diversified pharmaceutical drugs are distributed by Orspec Pharma.
|
|
| domain | founded_year | HQ Location |
Offers sales, distribution, and marketing services for health and beauty brands in pharmacies.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical distributor sourcing and supplying unlicensed products to healthcare providers in Australia.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ebos Group
Frequently Asked Questions about EBOS Group
When was EBOS Group founded?
EBOS Group was founded in 1922 and raised its 1st funding round 97 years after it was founded.
Where is EBOS Group located?
EBOS Group is headquartered in Docklands, Australia. It is registered at Docklands, Victoria, Australia.
Who is the current CEO of EBOS Group?
John Cullity is the current CEO of EBOS Group.
How many employees does EBOS Group have?
As of Jun 30, 2025, the latest employee count at EBOS Group is 5,700.
What is the annual revenue of EBOS Group?
Annual revenue of EBOS Group is $7.85B as on Jun 30, 2025.
What does EBOS Group do?
EBOS Group was founded in 1922 and is headquartered in Docklands, Australia. Operations focus on the wholesale and distribution of healthcare, medical, and pharmaceutical products within the healthcare sector. Additional services provided include warehousing, logistics support, laboratory supplies, and life science products. The company serves markets through its established supply chain infrastructure.
Who are the top competitors of EBOS Group?
EBOS Group's top competitors include AmerisourceBergen, Arrow Pharmacueticals and Orspec Pharma.
What products or services does EBOS Group offer?
EBOS Group offers Healthcare Distribution, Animal Care Products, and Medical Devices.
Is EBOS Group publicly traded?
Yes, EBOS Group is publicly traded on NZX under the ticker symbol EBO.
How many acquisitions has EBOS Group made?
EBOS Group has made 3 acquisitions, including LifeHealthcare, Symbion, and TerryWhite Chemmart.
What is EBOS Group's ticker symbol?
The ticker symbol of EBOS Group is EBO on NZX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.